Navigation Links
Verenium To Present At The Deutsche Bank 2012 Clean Tech, Utilities & Power Conference
Date:5/7/2012

SAN DIEGO, May 7, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that Janet Roemer, Executive Vice President and Chief Operating Officer, will present at the upcoming Deutsche Bank Clean Tech, Utilities and Power Conference as part of the biofuels panel.  The panel is scheduled to begin at 2:15 p.m. ET on Monday, May 14, 2012 in New York City.

About Verenium
Verenium, an industrial biotechnology company, is a global leader in developing high-performance enzymes.  Verenium's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries, including the global food and fuel markets.  Read more at www.verenium.com.

Forward-Looking Statements
Statements in this press release that are not strictly historical are "forward-looking" and involve a high degree of risk and uncertainty.  These include, but are not limited to, statements related to Verenium's technology, products and product candidates, lines of business, operations, capabilities, commercialization activities, corporate partnerships, target markets, future financial performance, and near-term and longer-term growth and prospects.  Such statements are only predictions, and actual events or results may differ materially from those projected in such forward-looking statements.  Factors that could cause or contribute to the differences include, but are not limited to, risks associated with Verenium's strategic focus, technologies, products and product candidates, dependence on patents and proprietary rights,  protection and enforcement of its patents and proprietary rights, the commercial prospects of the indus
'/>"/>

SOURCE Verenium Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Verenium Announces 2010 Business Update and Outlook for 2011
2. Verenium Announces Changes in Senior Management
3. Verenium Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2010
4. Verenium Corporation to Announce First Quarter 2011 Financial Results
5. Verenium Reports Financial Results for the First Quarter Ended March 31, 2011
6. Verenium to Host Analyst and Investor Day
7. Verenium Launches Second Enzyme Product for Oilfield Services
8. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
9. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
10. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013  Avanir Pharmaceuticals, Inc. (NASDAQ: ... overview of the company at the following conferences. ... Presentation date: Wednesday May 29, 2013 , Presentation time: ... Healthcare Conference , Presentation date: Wednesday June 5, 2013 ... A live webcast and 30-day archive of ...
(Date:5/22/2013)... PHILADELPHIA , 22. Mai 2013 /PRNewswire/ ... Sitz in Barcelona , ... aufzeigt, dass eine höhere Dosis von PROLASTIN©-C ... Patienten mit Alpha1-Antitrypsinmangel (AAT) auf ein Niveau ... normal bezeichneten Bereichs liegt. ATT-Mangel ist eine ...
(Date:5/22/2013)...  Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical company ... medical needs, today announced the appointment of ... Board of Directors. Dr. Almenoff has extensive experience in ... drug development. "We are delighted to ... Taraporewala, CEO of Ohr Pharmaceutical. "She offers tremendous expertise ...
Breaking Medicine Technology:Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 2Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 3
... PXS) today announced significant results of pooled data from ... of Bronchitol (inhaled mannitol) in people with cystic fibrosis. ... the first time at the North American Cystic Fibrosis ... results from the second trial (CF302) have been released ...
... Oct. 22 INVO Bioscience, Inc. (OTC Bulltin Board: ... for patients diagnosed with infertility, today announced that Dr. ... (CECOFLES LTDA) will present the results of the first ... INVO Bioscience,s INVOcell technology at the 66th Annual Meeting ...
Cached Medicine Technology:Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results 2Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results 3Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results 4Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results 5INVOcell Study Results to be Reported at the Annual Meeting of The American Society of Reproductive Medicine 2INVOcell Study Results to be Reported at the Annual Meeting of The American Society of Reproductive Medicine 3
(Date:5/22/2013)... Digital Advertising Agency, 21Digital , has ... media management client, Primal Pit Paste . One ... all-natural organic deodorant. The contest is part of a ... deodorant company based in Tampa, Florida. 21Digital president, Kevin ... a Facebook page is a great way to drive ...
(Date:5/22/2013)... 2013 With the health of a growing ... is no surprise that many women become hyperaware of everything ... two lines appear on a pregnancy test. At no other ... avoid unhealthy habits (like caffeine, alcohol, and nicotine) stronger than ... on their bodies? Does this increased awareness during pregnancy extend ...
(Date:5/22/2013)... 2013 Garcinia cambogia select is a dual ... inhibiting the extra fat being stored in the body. For ... intake. This fat burner helps people in this regard by ... overeating. Basically it does this by secreting a hormone serotonin ... them away from emotional overeating. In this way, it keeps ...
(Date:5/22/2013)... May 22, 2013 GS1 has honored ... Smucker Company, and Danny Wegman, CEO, Wegmans Food ... GS1 General Assembly and Global Leadership Summit, held May ... Wegman were recognized for their outstanding contributions to the ... broadly used supply chain standards globally. , “The ...
(Date:5/22/2013)... -- Children and teens exposed to radiation during CT ... according to a large, long-term study. The risks, ... young people who each had one CT scan, only ... within 10 years, according to researchers from Australia and ... the risks to patients when making decisions about CT ...
Breaking Medicine News(10 mins):Health News:Social Media Management Firm, 21Digital, Launches National Facebook Sweepstakes for Client, Primal Pit Paste 2Health News:Fairhaven Health Launches New PregnancyPlus Natural Deodorant Designed Specifically for Pregnant Women 2Health News:Garcinia Cambogia Reviews Released Online for Fast Weight Loss Solution with Offer of Extra 3 Month Supply 2Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 2Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 3Health News:Children Who Have CT Scans May Face Higher Cancer Risk 2
... on mental health is reportedly very high, accounting for ... an official at a recent// medical-care symposium in the ... is expected to rise further to 25 percent in ... Control and Prevention Department of the Ministry. A total ...
... been designed by scientists belonging to the Johns Hopkins University ... treatment, to the body// of a patient. The study has ... the cubes look like a flattened box, but when heat ... cube shape. ,"The self-assembly technique allows us to ...
... of AIDS research has revealed that the Government will have ... that there is a lack of incentive to //private players ... Research Chief made this announcement at an employment lawsuit. Such ... the vaccine really works. ,Strong reservations have been ...
... presence of H5N1 bird flu strain in the poultry samples ... bird flu strain // in six villages Modelu, Traian, Reviga, ... this month five new cases of bird flu strains was ... detected in Danube delta in Romania this October which is ...
... resolution has been passed in United Kingdom which allows ... of 12 and pregnant women as the risk associated ... with nicotine patches as earlier the sale of nicotine ... feeding women and people with chronic diseases such as ...
... first Chinese outbreak of H5N1 bird flu infection occurred from ... the Chinese officials have confirmed // the seventh death in ... was a 41 year old women factory worker of Sanming ... pneumonia, who had an initial H5N1 virus test negative. The ...
Cached Medicine News:Health News:Nanocubes Designed For Delivering Cells 2
... Pipetman Ultra is a fully adjustable, air-displacement ... It is the latest member of the ... characteristics: robustness, accuracy, and precision. We also ... feedback from our customers. Eight models cover ...
... The AlphaPette Pipettor is the #1 ... Offers accuracy, comfort, and reliability. Continuously ... volume readout sub-micrometer. Easy interchangeable ejector ... tiny hands. Adjustable rapid pipet tip ...
... Finnpipette Focus from Thermo Labsystems was designed ... Advanced features such as the new ... adjustment on microvolumes help to define this ... pipettes. The new interchangeable handle plate offers ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,408-9) or contact custom...
Medicine Products: